From January 2011 to October 2012 , 36 ( 26 males , 10 females , mean age 81.9 years ) patients with chronic heart failure ( NYHA class III-IV ) were randomized to PREFER and 36 ( 25 males , 11 females , mean age 76.6 years ) to the control group at a single centre .